JP7129682B2 - food composition - Google Patents
food composition Download PDFInfo
- Publication number
- JP7129682B2 JP7129682B2 JP2017072193A JP2017072193A JP7129682B2 JP 7129682 B2 JP7129682 B2 JP 7129682B2 JP 2017072193 A JP2017072193 A JP 2017072193A JP 2017072193 A JP2017072193 A JP 2017072193A JP 7129682 B2 JP7129682 B2 JP 7129682B2
- Authority
- JP
- Japan
- Prior art keywords
- processed
- mass
- cabbage
- fermentation
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 66
- 235000013305 food Nutrition 0.000 title claims description 27
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 68
- 240000007124 Brassica oleracea Species 0.000 claims description 66
- 150000001413 amino acids Chemical class 0.000 claims description 66
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 65
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 65
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 65
- 241000894006 Bacteria Species 0.000 claims description 44
- 235000002566 Capsicum Nutrition 0.000 claims description 44
- 238000010521 absorption reaction Methods 0.000 claims description 34
- 239000004310 lactic acid Substances 0.000 claims description 34
- 235000014655 lactic acid Nutrition 0.000 claims description 34
- 230000001737 promoting effect Effects 0.000 claims description 23
- 240000008574 Capsicum frutescens Species 0.000 claims description 17
- 239000001390 capsicum minimum Substances 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 description 70
- 239000000047 product Substances 0.000 description 70
- 238000000855 fermentation Methods 0.000 description 63
- 230000004151 fermentation Effects 0.000 description 63
- 235000001014 amino acid Nutrition 0.000 description 59
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 39
- 239000006002 Pepper Substances 0.000 description 32
- 235000016761 Piper aduncum Nutrition 0.000 description 32
- 240000003889 Piper guineense Species 0.000 description 32
- 235000017804 Piper guineense Nutrition 0.000 description 32
- 235000008184 Piper nigrum Nutrition 0.000 description 32
- 239000000126 substance Substances 0.000 description 30
- 102000007544 Whey Proteins Human genes 0.000 description 26
- 108010046377 Whey Proteins Proteins 0.000 description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- 108090000526 Papain Proteins 0.000 description 22
- 239000004365 Protease Substances 0.000 description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 22
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 22
- 229940055729 papain Drugs 0.000 description 22
- 235000019834 papain Nutrition 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000005862 Whey Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 19
- 239000000284 extract Substances 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 16
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 14
- 208000002720 Malnutrition Diseases 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000000463 material Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 11
- 240000004160 Capsicum annuum Species 0.000 description 10
- 230000009471 action Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 235000007862 Capsicum baccatum Nutrition 0.000 description 9
- 235000002568 Capsicum frutescens Nutrition 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 239000001728 capsicum frutescens Substances 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 208000003286 Protein-Energy Malnutrition Diseases 0.000 description 8
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 8
- 235000015165 citric acid Nutrition 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 235000020826 protein-energy malnutrition Nutrition 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 235000000824 malnutrition Nutrition 0.000 description 6
- 230000001071 malnutrition Effects 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 208000015380 nutritional deficiency disease Diseases 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 241000589220 Acetobacter Species 0.000 description 5
- 231100000002 MTT assay Toxicity 0.000 description 5
- 238000000134 MTT assay Methods 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 235000021119 whey protein Nutrition 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 240000006024 Lactobacillus plantarum Species 0.000 description 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 4
- 241001247145 Sebastes goodei Species 0.000 description 4
- 235000017663 capsaicin Nutrition 0.000 description 4
- 229960002504 capsaicin Drugs 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 230000031891 intestinal absorption Effects 0.000 description 4
- 229940072205 lactobacillus plantarum Drugs 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 235000019633 pungent taste Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000012981 Hank's balanced salt solution Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000003169 placental effect Effects 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 208000005156 Dehydration Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 210000002469 basement membrane Anatomy 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000006999 cognitive decline Effects 0.000 description 2
- 208000010877 cognitive disease Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 108010002430 hemicellulase Proteins 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 235000021075 protein intake Nutrition 0.000 description 2
- 108010070456 protopectinase Proteins 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 244000283763 Acetobacter aceti Species 0.000 description 1
- 235000007847 Acetobacter aceti Nutrition 0.000 description 1
- 241000589212 Acetobacter pasteurianus Species 0.000 description 1
- 241000583531 Alpinia purpurata Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 235000011302 Brassica oleracea Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000589216 Komagataeibacter hansenii Species 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000019604 hot taste sensations Nutrition 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940040511 liver extract Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 108020004410 pectinesterase Proteins 0.000 description 1
- 230000002351 pectolytic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- -1 rounds Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
本発明は食品組成物に関し、詳しくは、トウガラシ処理物とキャベツ処理物を含むことを特徴とする食品組成物に関する。 TECHNICAL FIELD The present invention relates to a food composition, and more particularly to a food composition characterized by containing a processed red pepper and a processed cabbage.
近年の高齢化の進展によって、たんぱく質やエネルギーの低栄養状態(PEM:protein energy malnutrition)が問題となっている。PEM患者は体重の減少や免疫機能の低下が起こり、罹患率の上昇を引き起こしている。また、PEM患者以外でも、筋力増強や健康のために効率のよいアミノ酸吸収方法が求められている。この様な状況に対して、タンパク質の摂取を促進する食品が複数考案されている。たとえば、特許文献1には、流動性が高く嚥下しやすいタンパク質含有組成物が開示されている。 Due to the progress of aging in recent years, protein and energy malnutrition (PEM: protein energy malnutrition) has become a problem. Patients with PEM experience weight loss and compromised immune function, leading to increased morbidity. In addition, there is a demand for an efficient amino acid absorption method for improving muscle strength and health even in patients other than PEM patients. In response to this situation, a number of food products have been devised to promote protein intake. For example, Patent Document 1 discloses a protein-containing composition that has high fluidity and is easy to swallow.
特許文献2には、天然物に微量しか存在しないショウガオール類を収率良く得ることができる合成用中間体が開示されている。さらに、特許文献3には、抗炎症剤の製造を容易にする、関節炎等の予防に有用な複数の成分をアカショウガの抽出成分から得る方法が開示されている。 Patent Literature 2 discloses a synthetic intermediate that enables a high yield of shogaols, which are present only in trace amounts in natural products, to be obtained. Further, Patent Document 3 discloses a method for obtaining a plurality of components useful for preventing arthritis and the like from extract components of red ginger, which facilitates the production of anti-inflammatory agents.
しかしながら、タンパク質の摂取、咀嚼・嚥下性の改善方法や、健康促進用の天然抽出物の合成方法や抽出方法については検討されているが、腸管におけるアミノ酸吸収については十分に検討されているとはいえない。本発明の課題は、アミノ酸の吸収促進作用が飛躍的に向上したアミノ酸の吸収促進剤を提供することにある。 However, although methods for improving protein intake, mastication and swallowing, and methods for synthesizing and extracting natural extracts for health promotion have been studied, it is unlikely that amino acid absorption in the intestinal tract has been adequately studied. I can't say An object of the present invention is to provide an amino acid absorption enhancer that has a dramatically improved amino acid absorption enhancer.
本発明者らは、アミノ酸の吸収促進を高める成分について鋭意研究したところ、驚くべきことに、トウガラシ処理物とキャベツ処理物とを組み合わせたところ、各処理物単独では見られなかったアミノ酸の吸収促進作用を、飛躍的に向上させることができることを見いだし、本発明を完成するに至った。即ち、トウガラシ処理物とキャベツ処理物とを組み合わせることで、アミノ酸の吸収促進能を向上させることができることを見いだした。このことは、非常に優れたアミノ酸吸収促進作用が得られることを示す。 The present inventors conducted intensive research on ingredients that enhance the absorption of amino acids. Surprisingly, when the processed pepper and the processed cabbage were combined, the absorption of amino acids was enhanced, which was not observed with each processed product alone. The inventors have found that the action can be dramatically improved, and have completed the present invention. That is, the present inventors have found that the ability to promote absorption of amino acids can be improved by combining a processed red pepper and a processed cabbage. This indicates that a very excellent amino acid absorption-enhancing action can be obtained.
上記の結果として、本発明者らは、身体に有用な組成物、とりわけアミノ酸吸収促進などの用途に供し得る組成物として、トウガラシ処理物とキャベツ処理物とを含有する組成物を創作することに成功した。本発明は、かかる知見や成功例に基づいて完成された発明である。 As a result of the above, the present inventors decided to create a composition containing a processed red pepper and a processed cabbage as a composition useful for the body, especially a composition that can be used for applications such as promoting amino acid absorption. Successful. The present invention is an invention completed based on such knowledge and successful examples.
したがって、本発明によれば、以下[1]~[4]の組成物が提供される。
[1]トウガラシ処理物とキャベツ処理物とを含むことを特徴とする食品組成物。
[2]トウガラシ処理物及び/又はキャベツ処理物が発酵処理物であることを特徴とする[1]に記載の食品組成物。
[3]アミノ酸をさらに含むことを特徴とする[1]又は[2]に記載の食品組成物。
[4]アミノ酸吸収促進用であることを特徴とする[1]ないし[3]のいずれか一項に記載の食品組成物。
Therefore, according to the present invention, the following compositions [1] to [4] are provided.
[1] A food composition comprising a processed red pepper and a processed cabbage.
[2] The food composition according to [1], wherein the processed pepper and/or processed cabbage is a fermented product.
[3] The food composition of [1] or [2], further comprising an amino acid.
[4] The food composition according to any one of [1] to [3], which is for promoting amino acid absorption.
本発明の一態様の組成物は、含有成分がいずれも日常摂取経験のある成分であり、摂取するに際して安全でありながら、アミノ酸吸収促進作用を通じて低栄養状態の改善や筋肉増強や健康に良好な効果を奏することができる。本発明の一態様の組成物は、このような作用を有することにより、タンパク質・エネルギー欠乏(PEM:Protein energy malnutrition)、低栄養、脱水、認知機能低下、骨量減少、免疫力、筋力、体力低下、罹患率の増加、脱水症状などの症状の予防・改善作用をより高めることが期待できる。 The composition of one aspect of the present invention contains all ingredients that have been ingested on a daily basis, is safe when ingested, and is good for improving malnutrition, muscle building, and health through the action of promoting amino acid absorption. It can be effective. The composition of one aspect of the present invention, by having such effects, is effective against protein energy malnutrition (PEM), malnutrition, dehydration, cognitive decline, bone loss, immunity, muscle strength, and physical strength. It can be expected to further enhance the preventive and ameliorative action of symptoms such as reduction, increase in morbidity, and dehydration.
以下、本発明の一態様である組成物の詳細について説明するが、本発明の技術的範囲は本項目の事項によってのみに限定されるものではなく、本発明はその目的を達成する限りにおいて種々の態様をとり得る。 Hereinafter, the details of the composition, which is one embodiment of the present invention, will be described. can take the form of
本発明の一態様である組成物は、アミノ酸吸収促進作用に有用な成分として、トウガラシ処理物とキャベツ処理物とを含むことが好ましい。 The composition that is one aspect of the present invention preferably contains a processed red pepper and a processed cabbage as components useful for promoting amino acid absorption.
[トウガラシ処理物]
本発明に用いられるトウガラシ処理物において使用できる植物体は、カプサイシン又はカプサイシノイド様物質を含む植物体であれば特に限定されないが、トウガラシ属の植物体が挙げられる。トウガラシ属の植物体は、品種、産地などに特に限定されない。具体的には、トウガラシ品種CH-19甘、伏見甘長、シシトウ、山科、万願寺、鷹の爪、香川本鷹、青森鷹の爪、札幌大長、カリフォルニア・ワンダー、チェリーボムなどが挙げられる。カプサイシノイド様物質を含有する植物体としては、例えば、上記のトウガラシ品種CH-19甘、該品種と他のトウガラシ属植物(カリフォルニアワンダー、シシトウなど)との交配種が挙げられる。上記植物体は、単独で用いても、二以上を組み合わせて用いてもよい。トウガラシ属の植物体が好適に用いられ、特に、伏見甘長は、果実が大ぶりであることに加え、辛味が少ないため、好適に用いられる。
[Processed hot pepper]
The plant body that can be used in the processed pepper product used in the present invention is not particularly limited as long as it contains a capsaicin- or capsaicinoid-like substance, and includes a plant body belonging to the genus Capsicum. Plants belonging to the genus Capsicum are not particularly limited in variety, place of production, and the like. Specific examples include pepper cultivars CH-19 sweet, Fushimi Kancho, Shishito, Yamashina, Manganji, Takanotsume, Kagawa Hontaka, Aomori Takanotsume, Sapporo Daicho, California Wonder, Cherry Bomb, and the like. Plants containing a capsaicinoid-like substance include, for example, the above-mentioned Pepper cultivar CH-19 sweet, and hybrids of this cultivar with other Capsicum plants (California Wonder, Shishito, etc.). The above plants may be used singly or in combination of two or more. A plant belonging to the genus Capsicum is preferably used, and Fushimi Kancho is particularly preferably used because of its large fruit size and low pungent taste.
トウガラシ処理物を得るためには、植物体は、カプサイシンまたはカプサイシノイド様物質を含有する部位であれば、どの部位を用いてもよい。特に、トウガラシ属の植物体においては、カプサイシンまたはカプサイシノイド様物質は胎座部に多く含まれているため、胎座部または胎座部を含む果実を用いることが好ましい。また、植物体は、生のまま用いてもよいし、植物体の乾燥物やその粉砕物を用いてもよいし、搾汁や抽出物を用いてもよいし、搾汁や抽出物を乾燥させた乾燥粉末等の加工品を用いても良い。これらの植物体を発酵処理することによって、トウガラシ処理物が得られる。 Any part of the plant may be used as long as it contains capsaicin or a capsaicinoid-like substance in order to obtain a processed pepper product. In particular, capsaicin or a capsaicinoid-like substance is abundantly contained in the placental part of a Capsicum plant, so it is preferable to use the placental part or fruit containing the placental part. In addition, the plant body may be used as it is, may be used as a dried plant body or its pulverized product, may be used as a juice or extract, or may be dried as a juice or extract. A processed product such as a dried powder may also be used. By fermenting these plants, a processed pepper is obtained.
上記植物体は、そのまま後述する発酵処理等に供することも可能であるが、植物体の表面積を増加させて効率よく植物体を発酵処理する点から、予め植物体を破砕することが好ましい。例えば、植物体をスライサーまたはダイサーでカットした後に、マスコロイダー、ブレンダー、摩砕ミルなどで、破砕片の粒径が、好ましくは100~3000μm、より好ましくは200~1000μmになるまで破砕する。必要に応じて、水、エタノールなどを適宜加えて破砕してもよい。 Although the plant body can be directly subjected to the fermentation treatment or the like described later, it is preferable to crush the plant body in advance in order to increase the surface area of the plant body and efficiently perform the fermentation treatment of the plant body. For example, after cutting the plant body with a slicer or dicer, it is crushed with a masscolloider, blender, grinding mill or the like until the particle size of the crushed pieces is preferably 100 to 3000 μm, more preferably 200 to 1000 μm. If necessary, water, ethanol, or the like may be appropriately added for crushing.
上記植物体またはその加工物に予め水を加えることが、発酵処理を効率よく行い得るという点から好ましい。加える水の量は、植物体またはその加工物の全質量に対して、等量~10倍量、好ましくは2倍量~5倍量、より好ましくは2倍量~4倍量である。水を加えることによって、加熱処理においては、熱の伝導効率が高まり、そして発酵処理においては、菌の生育環境が好適になる。 Preliminary addition of water to the plant body or its processed product is preferable from the viewpoint that the fermentation treatment can be performed efficiently. The amount of water to be added is equal to 10 times, preferably 2 to 5 times, more preferably 2 to 4 times the total mass of the plant body or processed product thereof. The addition of water increases heat transfer efficiency in heat treatment, and provides a favorable growth environment for bacteria in fermentation treatment.
発酵処理を行う前に、予め植物体またはその加工物に対して加熱処理を行ってもよい。発酵処理前に加熱処理を行うと、加熱処理によって脂肪酸が生成するため、発酵処理の比較的早い段階でこの脂肪酸が資化され、短時間で香りなどの嗜好性を高めることができる。特に、酵母や酢酸菌を用いて発酵を行う場合は、発酵処理前に加熱処理を行うことによって、雑菌の繁殖を抑えることができる。 The plant body or its processed product may be heat-treated in advance before the fermentation treatment. When heat treatment is performed before fermentation treatment, fatty acids are produced by the heat treatment, and these fatty acids are assimilated at a relatively early stage of the fermentation treatment, and palatability such as aroma can be enhanced in a short period of time. In particular, when fermentation is performed using yeast or acetic acid bacteria, propagation of various bacteria can be suppressed by performing heat treatment before fermentation treatment.
加熱処理は、植物体またはその加工物を、40℃~120℃の範囲の温度で30分~24時間加熱することによって行われる。特に、カプサイシノイド様物質を含有する植物体においては、効率よく分解物(脂肪酸など)を生じさせるために、高い加熱温度で短時間処理することが好ましい。例えば、40℃~60℃にて3時間~24時間、または60℃~120℃にて30分間~3時間処理することが好ましい。また、酢酸、焼成カルシウムなどを用いてpHを5~6.5または8~10に調整することにより、より低い加熱温度で処理することも可能である。このような高温かつ短時間での処理あるいは低温での処理により、カプサイシノイド様物質以外の成分の変性(色素の変化による材料の褐変など)を避けることができる。 The heat treatment is carried out by heating the plant body or its processed material at a temperature in the range of 40° C. to 120° C. for 30 minutes to 24 hours. In particular, plants containing capsaicinoid-like substances are preferably treated at a high heating temperature for a short period of time in order to efficiently produce decomposition products (such as fatty acids). For example, it is preferable to treat at 40° C. to 60° C. for 3 hours to 24 hours, or at 60° C. to 120° C. for 30 minutes to 3 hours. It is also possible to treat at a lower heating temperature by adjusting the pH to 5-6.5 or 8-10 using acetic acid, calcined calcium, or the like. Such high-temperature and short-time treatment or low-temperature treatment can avoid denaturation of components other than the capsaicinoid-like substance (such as browning of the material due to change in pigment).
次いで、植物体またはその加工物を発酵処理する。発酵処理は、例えば、植物体に含まれるカプサイシノイド様物質などを分解する。発酵処理は、有機酸を産生し得、かつカプサイシノイド様物質などの分解により生成する脂肪酸を資化し得る微生物を、上記植物体またはその加工物と接触させて行われる。微生物によって産生される有機酸などによるpHの変化などにより、カプサイシノイド様物質などが分解される。 Next, the plant body or its processed product is fermented. Fermentation decomposes, for example, capsaicinoid-like substances contained in plant bodies. Fermentation treatment is carried out by bringing a microorganism capable of producing organic acids and assimilating fatty acids produced by decomposition of capsaicinoid-like substances into contact with the plant body or its processed product. Capsaicinoid-like substances and the like are decomposed by changes in pH caused by organic acids produced by microorganisms.
植物体またはその加工物に微生物を接触させる態様としては、例えば、植物体またはその加工物に付着している微生物をそのまま利用することおよび植物体またはその加工物に微生物を添加することが挙げられる。植物体またはその加工物に微生物を添加することがより好ましい。植物体またはその加工物に付着している微生物をそのまま利用する場合には、植物体またはその加工物が腐敗する恐れがあるため注意を要する。 Examples of the mode of bringing the microorganism into contact with the plant body or its processed product include using the microorganism attached to the plant body or its processed product as it is and adding the microorganism to the plant body or its processed product. . It is more preferable to add microorganisms to the plant body or its processed product. When using the microorganisms adhering to the plant body or its processed material as they are, caution is required because the plant body or its processed material may rot.
発酵としては、乳酸発酵、クエン酸発酵、アルコール発酵、酢酸発酵、これらの組み合わせによる発酵などが挙げられる。発酵の種類に応じて、乳酸菌、酵母菌、酢酸菌などを植物体またはその加工物と接触させる。これらの菌は、単独で発酵に用いてもよいし、複数の菌を同時に添加して発酵に用いてもよいし、段階的に異なる菌を添加して発酵に用いてもよい。これらの中でも、乳酸発酵が好ましい。 Fermentation includes lactic acid fermentation, citric acid fermentation, alcoholic fermentation, acetic acid fermentation, fermentation by a combination thereof, and the like. Depending on the type of fermentation, lactic acid bacteria, yeast, acetic acid bacteria, etc. are brought into contact with the plant body or its processed product. These bacteria may be used singly for fermentation, a plurality of bacteria may be added simultaneously and used for fermentation, or different bacteria may be added stepwise and used for fermentation. Among these, lactic acid fermentation is preferred.
乳酸発酵は、上記植物体またはその加工物と乳酸菌とを接触させることによって行われる。乳酸発酵は、例えば、カプサイシノイド様物質などを分解し、分解物を資化して有機酸を産生するだけでなく、発酵物を低いpHに維持できるため、他の雑菌の繁殖を防ぐことも可能である。また、乳酸菌により整腸作用を有する有機酸などが作られ、より胃腸機能改善効果の高い発酵物を得ることもできる。 Lactic acid fermentation is carried out by contacting the plant body or its processed product with lactic acid bacteria. Lactic acid fermentation, for example, decomposes capsaicinoid-like substances, utilizes the decomposed products to produce organic acids, and maintains the fermented product at a low pH, so it is possible to prevent the growth of other bacteria. be. In addition, lactic acid bacteria produce an organic acid that has an intestinal regulation effect, and a fermented product with a higher gastrointestinal function improving effect can be obtained.
乳酸菌としては、ロイコノストック・メセントロイデス、ラクトバチルス・プランタラム、ラクトバチルス・ブレビス、ラクトバチルス・アシドフィルス、ラクトバチルス・カゼイ、ストレプトコッカス・サーモフィラス、ストレプトコッカス・フェカリス、ビフィドバクテリウム・ロンガムなどが挙げられ、単独でまたは組み合わせて用いられる。例えば、単独で用いる場合、ラクトバチルス・プランタラムが、その耐酸性、生育温度、および増殖速度の面から好適である。 Examples of lactic acid bacteria include Leuconostoc mesentroides, Lactobacillus plantarum, Lactobacillus brevis, Lactobacillus acidophilus, Lactobacillus casei, Streptococcus thermophilus, Streptococcus faecalis, and Bifidobacterium longum. used alone or in combination. For example, when used alone, Lactobacillus plantarum is preferred in terms of its acid resistance, growth temperature, and growth rate.
乳酸菌を添加する場合、予め植物体またはその加工物に、植物体の細胞壁を分解する酵素を添加してもよい。このような酵素を添加することにより、植物体の細胞内に含まれる栄養分が溶出し、乳酸菌が資化し得る栄養分が多くなるため、乳酸菌の生育が良くなる。さらに、これらの酵素が植物の細胞壁(膜)へ作用する結果、植物体の乳酸菌発酵液中のセロビオース、セロオリゴ糖などの含量が多くなり、発酵液に機能性が付与されるという効果が得られる。これらの酵素としては、ペクチン分解酵素(例えば、ポリガラクツロナーゼ、ペクチンリアーゼ、ペクチンエステラーゼ、およびプロトペクチナーゼ)、セルロース分解酵素(例えば、セルラーゼ、およびヘミセルラーゼ)などが挙げられる。これらの酵素は混合して用いてもよい。具体的には、プロトペクチナーゼ、ヘミセルラーゼ、およびセルラーゼを含む製剤が好適に用いられる。これらは、植物体またはその加工物に対して0.001質量%~約0.2質量%程度添加されるが、用いる酵素の精製度により異なる。ポリガラクツロナーゼを用いる場合、この酵素の最適pHはアルカリ側にあるので、植物体またはその加工物のpHが低い場合は、注意を要する。 When adding lactic acid bacteria, an enzyme that decomposes the cell wall of the plant may be added in advance to the plant or its processed product. By adding such an enzyme, the nutrients contained in the cells of the plant body are eluted, and the amount of nutrients that can be assimilated by the lactic acid bacteria is increased, thereby improving the growth of the lactic acid bacteria. Furthermore, as a result of the action of these enzymes on the cell wall (membrane) of the plant, the content of cellobiose, cellooligosaccharides, etc. in the lactic acid bacteria fermented liquid of the plant body increases, and the fermented liquid has the effect of imparting functionality. . These enzymes include pectinolytic enzymes (eg, polygalacturonase, pectin lyase, pectinesterase, and protopectinase), cellulolytic enzymes (eg, cellulases, and hemicellulases), and the like. These enzymes may be mixed and used. Specifically, preparations containing protopectinase, hemicellulase, and cellulase are preferably used. These are added in an amount of about 0.001% by mass to about 0.2% by mass based on the plant body or its processed product, but this varies depending on the degree of purification of the enzyme used. When polygalacturonase is used, since the optimum pH of this enzyme is on the alkaline side, care should be taken when the pH of the plant body or its processed product is low.
乳酸菌が優先的に増殖できる環境をつくるため、植物体またはその加工物を含む反応液のpHを予め低くしておくことも好ましい。例えば、ラクトバチルス・プランタラムでは、pH4.0程度に調整してから発酵を開始すれば、短期間でその発酵を終了できる。植物体またはその加工物を含む反応液のpHを低下させる方法としては、例えば、植物体またはその加工物にpH低下剤を添加すること、あるいは植物体またはその加工物に電気分解処理して酸性化された水(電解水)を添加することが挙げられる。pH低下剤としては、塩酸、グルコン酸、クエン酸、酒石酸、リンゴ酸、アスコルビン酸、ソルビン酸などが挙げられる。発酵物の酸味を抑制するためには、グルコン酸が好ましい。これらのpH低下剤は、植物体またはその加工物を含む反応液中に約0.1質量%~1.2質量%程度となるように加えることが好ましく、グルコン酸では約1質量%、他の有機酸では約0.3質量%加えることが好ましい。電解水は、該処理に用いた有隔膜の電解槽における陽極側の水を使用する。得られた電解水のpHが低すぎる場合には、イオン交換水の添加によって調整すればよい。 In order to create an environment in which lactic acid bacteria can preferentially proliferate, it is also preferable to previously lower the pH of the reaction solution containing the plant body or its processed product. For example, in the case of Lactobacillus plantarum, if the pH is adjusted to about 4.0 before starting fermentation, the fermentation can be completed in a short period of time. As a method for lowering the pH of the reaction solution containing the plant body or its processed product, for example, a pH-lowering agent is added to the plant body or its processed product, or the plant body or its processed product is electrolyzed to make it acidic. addition of water (electrolyzed water) that has been converted into water. pH-lowering agents include hydrochloric acid, gluconic acid, citric acid, tartaric acid, malic acid, ascorbic acid, sorbic acid, and the like. Gluconic acid is preferred for suppressing the sourness of the fermented product. These pH-lowering agents are preferably added to the reaction solution containing the plant body or its processed product so as to be about 0.1% by mass to 1.2% by mass, and gluconic acid is about 1% by mass. is preferably added in an amount of about 0.3% by mass. As the electrolyzed water, the water on the anode side in the diaphragm electrolytic cell used for the treatment is used. If the pH of the obtained electrolyzed water is too low, it may be adjusted by adding ion-exchanged water.
また、乳酸菌の優先的な生育のために、グルタミン酸またはその塩を加えてもよい。グルタミン酸の量は、植物体またはその加工物100質量部に対して0.05~1質量部程度、好ましくは0.1~0.5質量部程度となるように添加され得る。 Also, glutamic acid or a salt thereof may be added for preferential growth of lactic acid bacteria. Glutamic acid can be added in an amount of about 0.05 to 1 part by mass, preferably about 0.1 to 0.5 part by mass, per 100 parts by mass of the plant body or processed product thereof.
乳酸菌代謝性の糖を添加してもよい。この糖の添加は、糖分含量が少ない植物(1質量%未満)を発酵させる場合に有用である。あるいは、発酵の促進および飲料として用いる場合の甘味の付加という目的で添加してもよい。添加される乳酸菌代謝性の糖は、乳酸菌が生育および発酵に利用し得る糖であり、例えば、庶糖、ぶどう糖、果糖、麦芽糖などが挙げられるが、これらに限定されない。これらの糖は、糖分が植物の糖分と合わせて約1~6質量%になるように加えることが好ましい。 A sugar metabolizable by lactic acid bacteria may be added. Addition of this sugar is useful when fermenting plants with a low sugar content (less than 1% by mass). Alternatively, it may be added for the purpose of promoting fermentation and adding sweetness when used as a beverage. The added lactic acid bacterium-metabolizable sugar is a sugar that can be used by lactic acid bacteria for growth and fermentation, and examples thereof include, but are not limited to, sucrose, glucose, fructose, maltose, and the like. These sugars are preferably added so that the sugar content combined with the sugar content of the plant is about 1 to 6% by mass.
乳酸菌は、上記植物体またはその加工物100質量部に対して、湿菌体質量で好ましくは0.005~5.0質量部、さらに好ましくは0.01~2.0質量部添加される。なお、市販の乳酸菌乾燥粉末を用いる場合は、約0.0005~1質量部を目安に添加すればよい。発酵温度は、通常4℃~50℃である。発酵時間は、発酵温度に応じて設定すればよく、特に制限はない。例えば、20℃~50℃で発酵を行う場合、6時間~72時間、好ましくは12時間~72時間である。特に、30℃~40℃で発酵を行う場合は、6時間~64時間、好ましくは12時間~64時間である。また、植物体の青臭みを抑えた発酵物を得るために4℃~10℃で発酵を行う場合は、5日間~14日間である。 Lactic acid bacteria are preferably added in an amount of 0.005 to 5.0 parts by mass, more preferably 0.01 to 2.0 parts by mass in terms of wet cell mass, per 100 parts by mass of the plant body or processed product thereof. When using a commercially available dry powder of lactic acid bacteria, about 0.0005 to 1 part by mass may be added as a guideline. Fermentation temperature is usually 4°C to 50°C. The fermentation time may be set according to the fermentation temperature, and is not particularly limited. For example, when fermentation is performed at 20°C to 50°C, the time is 6 hours to 72 hours, preferably 12 hours to 72 hours. In particular, when fermentation is performed at 30°C to 40°C, the time is 6 hours to 64 hours, preferably 12 hours to 64 hours. When the fermentation is performed at 4° C. to 10° C. in order to obtain a fermented product with suppressed grassy smell of the plant body, the period is 5 to 14 days.
乳酸発酵は、嫌気性条件下で行うことが好ましい。嫌気性条件は、上記植物体またはその加工物を発酵槽に入れた後、脱気することにより、または発酵槽を密封するか、窒素、二酸化炭素などのガスで満たすか、減圧することにより、あるいはそれらを組み合わせることにより得られる。嫌気性条件下で発酵を行うことにより、得られる発酵処理物の風味も良くなる。 Lactic acid fermentation is preferably performed under anaerobic conditions. Anaerobic conditions are obtained by degassing after putting the plant body or processed product thereof in a fermenter, or by sealing the fermenter, filling it with a gas such as nitrogen or carbon dioxide, or reducing the pressure. Or it is obtained by combining them. Fermentation under anaerobic conditions also improves the flavor of the resulting fermented product.
乳酸発酵においては、乳酸菌非代謝性の糖を加えて発酵を停止させることができる。このような糖としては、糖アルコール(例えば、ソルビトール)、オリゴ糖(例えば、マルトオリゴ糖、キトオリゴ糖、フラクトオリゴ糖)などが挙げられる。このようなオリゴ糖は、整腸作用、う蝕の予防などに効果があり、得られる発酵処理物に機能性を付与し得る。 In lactic acid fermentation, fermentation can be stopped by adding non-metabolizable sugars to lactic acid bacteria. Such sugars include sugar alcohols (eg, sorbitol), oligosaccharides (eg, maltooligosaccharides, chitooligosaccharides, fructooligosaccharides), and the like. Such oligosaccharides are effective for intestinal regulation, caries prevention, and the like, and can impart functionality to the resulting fermented product.
クエン酸発酵は、上記植物体またはその加工物に、酵母を好気性条件下で接触させて培養することによって行われる。酵母によって産生されるクエン酸も、発酵物のpHを低くし、例えば、カプサイシノイド様物質などの分解を促進し得る。さらに、酵母を用いて発酵処理を行う場合、酵母がビタミン類などを産生するため、栄養価が高く、嗜好性に優れた植物体発酵処理物を得ることができる。 Citric acid fermentation is carried out by bringing yeast into contact with the plant body or processed product thereof under aerobic conditions and culturing the yeast. Citric acid produced by yeast can also lower the pH of the fermentate and facilitate the breakdown of, for example, capsaicinoid-like substances. Furthermore, when fermentation is performed using yeast, the yeast produces vitamins and the like, so a fermented plant product with high nutritional value and excellent palatability can be obtained.
酵母としては、清酒酵母、ワイン酵母、ビール酵母、パン酵母などと呼ばれる酵母が挙げられる。好ましくは、サッカロミセス属、シゾサッカロミセス属などに属する酵母が用いられ、例えば、サッカロミセス・セレビシエ、サッカロミセス・パストリアヌス、シゾサッカロミセス・ポンベなどが挙げられる。特にビタミンなどの有用物質を産生する点で、サッカロミセス・セレビシエを用いることが好ましい。 Examples of yeast include yeast called sake yeast, wine yeast, beer yeast, baker's yeast, and the like. Preferably, yeast belonging to the genus Saccharomyces, Schizosaccharomyces, etc. is used, and examples thereof include Saccharomyces cerevisiae, Saccharomyces pastorianus, Schizosaccharomyces pombe and the like. In particular, Saccharomyces cerevisiae is preferably used because it produces useful substances such as vitamins.
酵母の添加量は、特に制限されない。好ましくは、植物体またはその加工物100質量部に対して、湿菌体または乾燥菌体質量で0.01~15質量部程度、好ましくは0.1~10質量部程度を添加する。 The amount of yeast added is not particularly limited. Preferably, about 0.01 to 15 parts by mass, preferably about 0.1 to 10 parts by mass, in terms of wet or dry cell mass, is added to 100 parts by mass of the plant body or processed product thereof.
クエン酸発酵は、植物体またはその加工物と酵母とを発酵槽に入れ、通気攪拌しながら、4℃~40℃、好ましくは10℃~35℃で12時間~14日間行う。 Citric acid fermentation is carried out by placing a plant body or a processed product thereof and yeast in a fermenter, and performing aeration and stirring at 4° C. to 40° C., preferably 10° C. to 35° C. for 12 hours to 14 days.
アルコール発酵は、酵母を、上記植物体またはその加工物と嫌気性条件下で接触させて培養することによって行われる。アルコール発酵に用いられる酵母の種類および量は、上記クエン酸発酵の場合と同様である。発酵条件も、嫌気性条件にすること以外は、上記クエン酸発酵の場合と同様である。こうしてアルコール発酵で得られた発酵処理物は、さらに以下で述べる酢酸発酵に供することが好ましい。 Alcoholic fermentation is carried out by bringing yeast into contact with the plant body or its processed product under anaerobic conditions and culturing it. The type and amount of yeast used for alcoholic fermentation are the same as those for citric acid fermentation. Fermentation conditions are also the same as in the above citric acid fermentation, except that they are anaerobic conditions. It is preferable that the fermented product thus obtained by alcoholic fermentation is further subjected to acetic acid fermentation described below.
酢酸発酵は、上記植物体またはその加工物にアルコールを添加して、所定のアルコール濃度にした後、酢酸発酵し得る微生物(酢酸菌)を添加して行われる。あるいは上記のアルコール発酵によって得られた発酵処理物に酢酸菌を添加して二段発酵させてもよい。 Acetate fermentation is carried out by adding alcohol to the plant body or its processed product to obtain a predetermined alcohol concentration, and then adding microorganisms capable of acetic acid fermentation (acetic acid bacteria). Alternatively, acetic acid bacteria may be added to the fermented product obtained by the above-mentioned alcoholic fermentation for two-stage fermentation.
アルコール濃度は、酢酸菌が生育できる濃度であれば、どのような濃度であってもよく、発酵時間などを考慮して、10質量/容量%以下にすることが好ましく、1~6質量/容量%が特に好ましい。 The alcohol concentration may be any concentration as long as it is a concentration at which acetic acid bacteria can grow, and considering the fermentation time etc., it is preferably 10 mass / volume % or less, and 1 to 6 mass / volume. % is particularly preferred.
酢酸菌としては、アセトバクター属に属する微生物、例えば、アセトバクター・アセチ、アセトバクター・パステウリアヌス、アセトバクター・ハンセニなどが挙げられる。 Examples of acetic acid bacteria include microorganisms belonging to the genus Acetobacter, such as Acetobacter aceti, Acetobacter pasteurianus, and Acetobacter hansenii.
酢酸菌は、適切な培地で15℃~40℃、好ましくは、25℃~35℃で、6~48時間予備培養しておくことが好ましい。予備培養した酢酸菌は、例えば、次のようにして得ることができる。ポテト200g、破砕酵母30g、肝臓エキス25g、肉エキス5g、チオグリコール酸培地10g、グルコース5g、グリセロール15g、および炭酸カルシウム15gを含有する1Lの酢酸菌培地(pH7.0)に酢酸菌を添加して、15℃~40℃で24時間予備培養する。次いで、培養物を遠心分離し、回収した菌を滅菌水で洗浄し、再度遠心分離し、上清を除去して、予備培養した酢酸菌を得る。 Acetobacter is preferably pre-cultured in an appropriate medium at 15°C to 40°C, preferably 25°C to 35°C, for 6 to 48 hours. Pre-cultured acetic acid bacteria can be obtained, for example, as follows. Acetobacter was added to 1 L of Acetobacter medium (pH 7.0) containing 200 g of potato, 30 g of crushed yeast, 25 g of liver extract, 5 g of meat extract, 10 g of thioglycolic acid medium, 5 g of glucose, 15 g of glycerol, and 15 g of calcium carbonate. and pre-incubated at 15°C to 40°C for 24 hours. Next, the culture is centrifuged, the recovered bacteria are washed with sterilized water, centrifuged again, and the supernatant is removed to obtain precultured acetic acid bacteria.
酢酸菌は、植物体またはその加工物、あるいは発酵処理物100質量部に対して、湿菌体質量で0.0001~1質量部、好ましくは0.01~0.5質量部を添加する。 Acetobacter is added in an amount of 0.0001 to 1 part by mass, preferably 0.01 to 0.5 part by mass of the wet cell mass, per 100 parts by mass of the plant body, processed product thereof, or fermented product.
酢酸発酵は、攪拌培養、振盪培養、または静置培養のいずれでも行うことができる。発酵温度は10℃~40℃、好ましくは20℃~35℃の間である。発酵時間は、酢酸菌の添加量に応じて適宜設定され、通常、1日~1週間が好適である。 Acetate fermentation can be carried out by stirring culture, shaking culture, or stationary culture. The fermentation temperature is between 10°C and 40°C, preferably between 20°C and 35°C. Fermentation time is appropriately set according to the amount of acetic acid bacteria added, and usually one day to one week is suitable.
上記のように、カプサイシンおよびカプサイシノイド様物質からなる群より選択される少なくとも1種を含有する植物体またはその加工物を発酵処理することによって、植物体発酵処理物を得ることができる。この発酵処理物を加熱処理してもよい。得られた植物体発酵処理物から発酵処理液を回収してもよい。発酵処理液の回収には当業者が通常用いる方法、例えば、遠心分離、濾過などが適用され得る。 As described above, a fermented plant product can be obtained by fermenting a plant containing at least one selected from the group consisting of capsaicin and capsaicinoid-like substances or a processed product thereof. This fermented product may be heat-treated. A fermented liquid may be recovered from the obtained fermented plant material. Methods commonly used by those skilled in the art, such as centrifugation and filtration, can be applied to recover the fermented liquid.
上記植物体発酵処理物に、さらに抽出処理を施してもよい。植物体発酵処理物中に含有される成分のうちで、アミノ酸吸収促進作用を有する成分は、主に水、エタノールなどに溶解する成分である。したがって、植物体発酵処理物から抽出を行い、得られた抽出物を用いてもよい。特に、カプサイシノイド様物質を含有する植物体またはその加工物を用いた植物体発酵処理物は、植物体中にはほとんど含有されないカプサイシノイド様物質の分解物、主としてバニリルアルコールを含有する。抽出物は、例えば、該植物体発酵処理物を必要に応じて粉砕し、水、エタノールなどの溶媒を加えて抽出を行い、当業者が通常用いる方法、例えば、遠心分離、濾過などにより植物体処理物の残渣を除去することによって得られる。なお、植物体を粉砕せずに発酵処理を行った場合には、抽出を容易にするために、上記処理後に粉砕してもよい。さらに、抽出物は、抽出に用いた溶媒の一部または全部を除去して、エキスとすることもできる。 The fermented plant material may be further subjected to an extraction treatment. Among the components contained in the fermented plant material, the components having amino acid absorption-promoting action are mainly those that dissolve in water, ethanol, and the like. Therefore, an extract obtained by performing extraction from a fermented plant body may be used. In particular, a fermented plant product using a plant body containing a capsaicinoid-like substance or a processed product thereof contains decomposition products of the capsaicinoid-like substance that are hardly contained in the plant body, mainly vanillyl alcohol. The extract can be obtained, for example, by pulverizing the fermented plant material if necessary, adding a solvent such as water or ethanol for extraction, and extracting the plant material by a method commonly used by those skilled in the art, such as centrifugation or filtration. Obtained by removing the residue of the processed material. In addition, when the fermentation treatment is performed without pulverizing the plant body, it may be pulverized after the above treatment in order to facilitate the extraction. Furthermore, the extract can be made into an extract by removing part or all of the solvent used for extraction.
本発明の組成物は、カプサイシン、またはカプサイシノイド様物質を含有する植物体を用いた場合には、その分解物を含有する。ここで、カプサイシノイド様物質の分解物の含有量は、カプサイシノイド様物質が上記処理によって主にバニリルアルコールと脂肪酸とに分解されることに基づいて、バニリルアルコールの含有量を指標として測定され得る。理論的には、1molのカプサイシノイド様物質が分解すると、1molのバニリルアルコールが生成され得る。したがって、バニリルアルコールの含有量を測定することによって、カプサイシノイド様物質の分解率およびカプサイシノイド様物質の分解物の生成量を知ることができる。バニリルアルコールは、例えば、HPLCによって測定し得る。特に、カプサイシノイド様物質の分解物を含有する場合は、アミノ酸吸収促進効果を効率的に発揮する点から、バニリルアルコールを指標として、乾燥質量換算で0.05質量%~0.3質量%含有することが好ましい。このバニリルアルコールの含有量は、処理前の含有量に比べて、1.5倍~25倍、好ましくは2~20倍に相当する。 When a plant body containing capsaicin or a capsaicinoid-like substance is used, the composition of the present invention contains its degradation product. Here, the content of decomposition products of the capsaicinoid-like substance can be measured using the content of vanillyl alcohol as an indicator, based on the fact that the capsaicinoid-like substance is mainly decomposed into vanillyl alcohol and fatty acids by the above treatment. . Theoretically, 1 mol of vanillyl alcohol can be produced when 1 mol of capsaicinoid-like substance decomposes. Therefore, by measuring the content of vanillyl alcohol, the decomposition rate of the capsaicinoid-like substance and the production amount of the decomposition product of the capsaicinoid-like substance can be known. Vanillyl alcohol can be measured, for example, by HPLC. In particular, when a decomposition product of a capsaicinoid-like substance is contained, it contains 0.05% to 0.3% by mass in terms of dry mass, using vanillyl alcohol as an index, from the viewpoint of efficiently exhibiting the effect of promoting amino acid absorption. preferably. The vanillyl alcohol content corresponds to 1.5 to 25 times, preferably 2 to 20 times, the content before treatment.
必要に応じて、本発明の組成物の殺菌処理を行う。殺菌処理は、気流殺菌、高圧殺菌、加熱殺菌などの当業者が通常用いる方法により行われ得る。殺菌は、各種の栄養分を保持するために、できるだけ低温かつ短時間で行うことが好ましい。殺菌処理により、長期間の保存が可能となる。 If necessary, the composition of the present invention is sterilized. The sterilization treatment can be carried out by methods commonly used by those skilled in the art, such as airflow sterilization, high-pressure sterilization, and heat sterilization. Sterilization is preferably performed at the lowest possible temperature and for the shortest possible time in order to retain various nutrients. Sterilization allows long-term storage.
上記のように処理されたトウガラシ処理物の含有量は、アミノ酸吸収促進作用が認められる量であれば特に限定されないが、後述する実施例に記載があるとおり、組成物全体に対して、0.0001~50質量%、好ましくは0.001~40質量%であり、特に好ましくは0.01~30質量%である。 The content of the processed pepper processed as described above is not particularly limited as long as it is an amount at which amino acid absorption promoting action is observed. 0001 to 50% by mass, preferably 0.001 to 40% by mass, and particularly preferably 0.01 to 30% by mass.
[キャベツ処理物]
キャベツ処理物は、キャベツを発酵させることにより得られる。キャベツは通常知られている通りのアブラナ科に属する一年生又は越年生草本であるキャベツ(Brassica Oleracea L.)であれば特に限定されない。
[Processed cabbage]
A processed cabbage product is obtained by fermenting cabbage. Cabbage is not particularly limited as long as it is a commonly known annual or biennial herb belonging to the Brassicaceae family (Brassica Oleracea L.).
キャベツの発酵に用いる菌の種類は特に限定されず、乳酸菌、酵母菌、麹菌、納豆菌などを用いることができるが、発酵物の味が良く、安全性が高いという点から、乳酸菌を用いることが特に好ましい。これらの菌は、単独でキャベツの発酵に用いてもよいし、複数の菌を同時に添加して発酵に用いてもよいし、段階的に異なる菌を添加して発酵に用いてもよい。キャベツを発酵させる方法には、例えば、キャベツに乳酸菌を添加して発酵する方法、乳酸菌は添加せず、キャベツに付着している乳酸菌を利用する方法などがあるが、本発明においてはそれらに限定されない。植物体の加工および発酵方法についてはトウガラシ処理物の記載事項を参照できる。 The type of bacteria used for cabbage fermentation is not particularly limited, and lactic acid bacteria, yeast, koji mold, natto bacteria, etc. can be used, but lactic acid bacteria are used because the fermented product has a good taste and is highly safe. is particularly preferred. These fungi may be used alone for fermentation of cabbage, a plurality of fungi may be added simultaneously and used for fermentation, or different fungi may be added stepwise and used for fermentation. Methods of fermenting cabbage include, for example, a method of adding lactic acid bacteria to cabbage and a method of using lactic acid bacteria attached to cabbage without adding lactic acid bacteria, but the present invention is limited to these. not. For the processing and fermentation methods of the plant body, reference can be made to the items described in processed pepper products.
本発明に用いるキャベツ処理物は、アブラナ科に属するキャベツに少なくとも乳酸菌を添加して発酵させることにより得られる物をいう。乳酸菌を添加し、キャベツを発酵させる方法としては、例えば、先ずキャベツを水洗いし、カッターで粉砕し、水および植物性乳酸菌(例えば、ラクトバチルス・プランタラム:乾燥粉末でも良い)を添加し、よく攪拌して、適切な温度で所定時間保持する方法がある。この時、キャベツ粉砕末にキャベツ濃縮液を添加して発酵させてもよい。キャベツを発酵させた後には、発酵物をそのまま発酵エキスとしても良い。または、遠心分離して上清を回収し、減圧濃縮して発酵エキスとして用いても良いし、濃縮後、凍結乾燥などの手段で乾燥粉末(エキス末)としても良い。あるいは、これらのエキスをさらに加熱殺菌し、デキストリンを加えてスプレードライすることにより乾燥粉末(エキス末)とすることもできる。本発明に用いられるキャベツ処理物には、これらの例示したキャベツ処理物、乾燥粉末(エキス末)、ペーストなどが含まれるがこれらに限定されない。このようなキャベツ処理物は、体内のSOD活性の増強作用、美容作用、健胃作用などを有する。 The processed cabbage product used in the present invention refers to a product obtained by adding at least lactic acid bacteria to cabbage belonging to the Brassicaceae family and fermenting the cabbage. As a method of adding lactic acid bacteria and fermenting cabbage, for example, the cabbage is first washed with water, pulverized with a cutter, water and vegetable lactic acid bacteria (for example, Lactobacillus plantarum: dry powder may be used) are added, and well. There is a method of stirring and holding at an appropriate temperature for a predetermined time. At this time, a cabbage concentrate may be added to the crushed cabbage powder for fermentation. After fermenting the cabbage, the fermented product may be used as the fermented extract as it is. Alternatively, the supernatant may be recovered by centrifugation, concentrated under reduced pressure and used as a fermented extract, or after concentration, may be dried powder (extract powder) by means of freeze-drying or the like. Alternatively, these extracts can be heat sterilized, added with dextrin, and spray-dried to obtain dry powder (extract powder). The processed cabbage products used in the present invention include, but are not limited to, the above-exemplified processed cabbage products, dried powders (extract powder), pastes, and the like. Such a processed cabbage product has an effect of enhancing SOD activity in the body, a cosmetic effect, a stomachic effect, and the like.
上記のように処理されたキャベツ処理物の含有量は、アミノ酸吸収促進作用が認められる量であれば特に限定されないが、後述する実施例に記載があるとおり、組成物全体に対して、0.0001~50質量%、好ましくは0.001~40質量%であり、特に好ましくは0.01~30質量%である。キャベツ処理物の含有量がこれらの範囲内にあることにより、トウガラシ処理物と相乗的なアミノ酸吸収促進作用が得られる組成物とすることができる。 The content of the processed cabbage processed as described above is not particularly limited as long as the amino acid absorption promoting action is observed. 0001 to 50% by mass, preferably 0.001 to 40% by mass, and particularly preferably 0.01 to 30% by mass. When the content of the processed cabbage is within these ranges, it is possible to obtain a composition that exhibits a synergistic amino acid absorption-enhancing effect with the processed red pepper.
[組成物]
トウガラシ処理物およびキャベツ処理物のそれぞれの含有量は上記したとおりであるが、これらの総量及び質量比については、本発明の一態様の組成物がアミノ酸吸収促進作用を示す限りにおいて特に限定されない。例えば、トウガラシ処理物およびキャベツ処理物の質量比(トウガラシ処理物:キャベツ処理物)は1:0.001~10であり、良好なアミノ酸吸収促進作用を得るためには、1:0.003~5であることが好ましく、1:0.005~2であることがより好ましい。
[Composition]
The respective contents of the processed pepper and the processed cabbage are as described above, but the total amount and mass ratio thereof are not particularly limited as long as the composition of one embodiment of the present invention exhibits an amino acid absorption-enhancing effect. For example, the mass ratio of processed pepper and processed cabbage (processed pepper:processed cabbage) is 1:0.001 to 10, and in order to obtain a good amino acid absorption promoting effect, 1:0.003 to 5 is preferred, and 1:0.005 to 2 is more preferred.
本発明の一態様の組成物は、アミノ酸吸収促進作用の程度については特に限定されないが、例えば、トウガラシ処理物およびキャベツ処理物を含有する系について、トウガラシ処理物およびキャベツ処理物の両方を含有しない系やトウガラシ処理物およびキャベツ処理物のいずれか一方のみを含有する系と比べて、アミノ酸吸収促進作用が見られる程度の作用である。 The composition of one embodiment of the present invention is not particularly limited in terms of the degree of amino acid absorption-enhancing action. Compared to a system containing only one of the processed chili pepper and the processed cabbage, the amino acid absorption-enhancing effect is observed.
本発明の一態様の組成物の具体的な態様は、組成物の総量に対して、トウガラシ処理物を0.0001~50質量%、好ましくは0.001~40質量%、特に好ましくは0.01~30質量%で含有し、キャベツ処理物を0.0001~50質量%、好ましくは0.001~40質量%、特に好ましくは0.01~30質量%で含有し、かつ、トウガラシ処理物及びキャベツ処理物の質量比(トウガラシ処理物:キャベツ処理物)が1:0.001~10、好ましくは1:0.003~5、より好ましくは1:0.005~2である組成物である。 In a specific aspect of the composition of one aspect of the present invention, 0.0001 to 50% by mass, preferably 0.001 to 40% by mass, particularly preferably 0.001 to 40% by mass, of the processed chili pepper relative to the total amount of the composition. 01 to 30% by mass, containing 0.0001 to 50% by mass of processed cabbage, preferably 0.001 to 40% by mass, particularly preferably 0.01 to 30% by mass, and processed pepper And a composition in which the mass ratio of the processed cabbage (processed hot pepper: processed cabbage) is 1: 0.001 to 10, preferably 1: 0.003 to 5, more preferably 1: 0.005 to 2 be.
上記のトウガラシ処理物とキャベツ処理物とを含む本発明の一態様の組成物の製造方法は特に限定されず、例えば、室温や加温下で、各成分を含有せしめることにより、粉末状、顆粒状又は固形状の組成物とすることができる。または、この組成物を、水などの溶媒に溶解させて液状組成物とすることができる。さらに、各成分の液状物に、他の固形状成分を加えて混合することにより液状組成物とすることができる。なお、得られた液状組成物は、乾燥処理を経て、粉末化しても良い。この場合の乾燥処理の方法としては、噴霧乾燥、凍結乾燥などが挙げられるが、これらに限定されない。 The method for producing the composition of one embodiment of the present invention containing the above-described processed pepper and processed cabbage is not particularly limited. It can be a composition in a shape or a solid form. Alternatively, the composition can be dissolved in a solvent such as water to form a liquid composition. Furthermore, a liquid composition can be obtained by adding and mixing other solid components to the liquid of each component. The obtained liquid composition may be pulverized through a drying treatment. Examples of the drying treatment method in this case include, but are not limited to, spray drying, freeze drying, and the like.
本発明の一態様の組成物は、食品組成物であり、アミノ酸吸収促進効果を期待した種々の形態で利用され得る。剤形は特に限定されないが、例えば、アミノ酸吸収促進用、特に腸からの吸収促進用(腸管吸収用)の食品組成物などの形態をとり得る。 A composition of one aspect of the present invention is a food composition, and can be used in various forms in anticipation of an amino acid absorption promoting effect. Although the dosage form is not particularly limited, for example, it may take the form of a food composition for promoting amino acid absorption, particularly for promoting absorption from the intestine (for intestinal absorption).
食品組成物の具体的な一態様は、例えば、生体に対して一定の機能性を有する食品である機能性飲食品である。機能性飲食品は、例えば、特定保健用飲食品、機能性表示飲食品、栄養機能飲食品、保健機能飲食品、特別用途飲食品、栄養補助飲食品、健康補助飲食品、サプリメント、美容飲食品などのいわゆる健康飲食品に加えて、乳児用飲食品、妊産婦用飲食品、高齢者用飲食品などの特定者用飲食品を包含する。さらに機能性飲食品は、コーデックス(FAO/WHO合同食品規格委員会)の食品規格に基づく健康強調表示(Health claim)が適用される健康飲食品を包含する。 A specific aspect of the food composition is, for example, a functional food or drink, which is a food having certain functionality for the living body. Food and drink with functional properties include, for example, food and drink for specified health use, food and drink with functional claims, food and drink with nutrient function, food and drink with health function, food and drink for special purposes, nutritional supplement food and drink, health supplement food and drink, supplements, and beauty food and drink. In addition to so-called healthy food and drink such as, food and drink for specific people such as food and drink for infants, pregnant women and elderly people. Furthermore, functional foods and drinks include health foods and drinks to which health claims based on food standards of Codex (FAO/WHO Joint Food Standards Committee) are applied.
本発明の一態様の組成物の摂取量は特に限定されず、摂取者に求められるアミノ酸吸収促進の程度や摂取態様などに応じて適宜設定され得るが、例えば、摂取1回量として、摂取者の体重を基準として、処理物成分の総量について100~2,000mg/kg、好ましくは300~1,500mg/kgであり、特に好ましくは500~1,000mg/kgである。 The intake amount of the composition of one embodiment of the present invention is not particularly limited, and can be appropriately set according to the degree of enhancement of amino acid absorption required by the intake person, the mode of intake, and the like. The total amount of the components of the processed product is 100 to 2,000 mg/kg, preferably 300 to 1,500 mg/kg, and particularly preferably 500 to 1,000 mg/kg, based on the body weight of the animal.
本発明の一態様の組成物の1日の摂取量は特に限定されず、例えば、処理物成分の総量について10~300g、好ましくは30~200gであり、特に好ましくは50~100gである。 The daily intake of the composition of one embodiment of the present invention is not particularly limited, and is, for example, 10 to 300 g, preferably 30 to 200 g, particularly preferably 50 to 100 g, with respect to the total amount of processed components.
上述したとおり、本発明の一態様の組成物の利用形態は特に限定されないが、例えば、経口摂取に適した形態、具体的には液状、粉末状、粒状、顆粒状、錠状、棒状、板状、ブロック状、固形状、丸状、ペースト状、ハードカプセルやソフトカプセルのようなカプセル状、カプレット状、タブレット状、ゲル状、スムージー様のとろみのある形状などの各形態が挙げられるが、摂取したときの吸収性が最も良く、効果がより高く得られる液状や顆粒状の形態であることが好ましい。 As described above, the form of use of the composition of one embodiment of the present invention is not particularly limited. shapes, blocks, solids, rounds, pastes, capsules such as hard capsules and soft capsules, caplets, tablets, gels, and thick smoothie-like shapes. It is preferably in the form of liquid or granules, which has the best absorbability and a higher effect.
本発明の一態様の組成物は、容器に詰めて密封した容器詰組成物とすることができる。容器は特に限定されないが、例えば、アルミなどの金属、紙、PETやPTPなどのプラスチック、1層又は積層(ラミネート)のフィルム袋、レトルトパウチ、真空パック、アルミ容器、プラスチック容器、瓶、缶などの包装容器が挙げられる。本発明の一態様の組成物は、経時的な変質を避けるために、容器に詰めて密封した後に、加圧及び/又は加熱などにより殺菌処理したものであることが好ましい。 The composition of one embodiment of the present invention can be a packaged composition that is packed and sealed in a container. Although the container is not particularly limited, for example, metal such as aluminum, paper, plastic such as PET and PTP, single-layer or laminated film bag, retort pouch, vacuum pack, aluminum container, plastic container, bottle, can, etc. packaging container. In order to avoid deterioration over time, the composition of one embodiment of the present invention is preferably sterilized by pressurization and/or heating after being sealed in a container.
本発明の一態様の組成物の使用方法は特に限定されないが、例えば、本発明の一態様の組成物をそのまま、水などとともに、又は水などで希釈するなどして、飲食することにより経口摂取することができる。摂取者の好みなどに応じて、本発明の一態様の組成物と他の固体物や液状物とを混ぜて経口摂取してもよい。本発明の一態様の組成物を口腔崩壊剤形とした場合は、水なしで経口摂取することができる。 The method of using the composition of one embodiment of the present invention is not particularly limited. can do. The composition of one embodiment of the present invention may be mixed with other solids or liquids and orally ingested according to the preferences of the ingestor. When the composition of one embodiment of the present invention is made into an orally disintegrating dosage form, it can be orally ingested without water.
本発明の一態様の組成物は、トウガラシ処理物とキャベツ処理物とを少なくとも含有すればよいが、これらとその他の成分とを組み合わせたものとすることができる。その他の成分としては特に限定されないが、例えば、増粘剤、光沢剤、製造用剤などをその他の成分として用いることができ、具体的にはアミノ酸等が挙げられる。アミノ酸としては、例えばピープロテイン、ライスプロテイン、アーモンドプロテイン、ホエイプロテイン、シルクプロテイン等のタンパク質に由来するアミノ酸が好ましい。これら以外にも、種々の賦形剤、結合剤、滑沢剤、安定剤、希釈剤、増量剤、乳化剤、着色料、香料、香油などをその他の成分として用いることができる。その他の成分の含有量は、本発明の一態様の組成物の形態などに応じて適宜選択することができる。 The composition of one embodiment of the present invention may contain at least a processed red pepper and a processed cabbage, and may be a combination of these and other components. Other components are not particularly limited, but may be, for example, thickeners, brightening agents, manufacturing agents, etc. Specific examples include amino acids. Preferred amino acids are those derived from proteins such as pea protein, rice protein, almond protein, whey protein and silk protein. In addition to these, various excipients, binders, lubricants, stabilizers, diluents, extenders, emulsifiers, colorants, perfumes, perfume oils, etc. can be used as other ingredients. The content of other components can be selected as appropriate depending on the form of the composition of one embodiment of the present invention.
本発明の一態様の組成物は、そのアミノ酸吸収促進作用を通じた効果により、これを使用することは、タンパク質・エネルギー欠乏(PEM:Protein energy malnutrition)、低栄養、脱水、認知機能低下、骨量減少、免疫力、筋力、体力低下、罹患率の増加、脱水症状などの症状の予防・改善作用に有用である。さらには、本発明の一態様の組成物は、筋力の衰えを感じる健常者、とりわけ中高年者に有用である。 The composition of one aspect of the present invention is effective through its amino acid absorption-enhancing action, and the use of the composition causes protein energy malnutrition (PEM), malnutrition, dehydration, cognitive decline, bone mass It is useful for preventing and improving symptoms such as decreased immunity, muscle strength, decreased physical strength, increased morbidity, and dehydration. Furthermore, the composition of one embodiment of the present invention is useful for healthy people, especially middle-aged and elderly people, who feel muscle weakness.
以下、本発明を実施例によりさらに詳細に説明するが、本発明はこれら実施例に限定されるものではなく、本発明の課題を解決し得る限り、本発明は種々の態様をとることができる。 The present invention will be described in more detail below with reference to Examples, but the present invention is not limited to these Examples, and the present invention can take various aspects as long as the problems of the present invention can be solved. .
以下のとおりに、トウガラシ処理物とキャベツ処理物とをそれぞれ用意し、これらの組み合わせを含有する組成物が格別顕著なアミノ酸の腸管吸収促進作用を有することを以下の通りに実証した。 Processed chili peppers and processed cabbage products were prepared as follows, and it was demonstrated as follows that a composition containing a combination of these has a remarkably enhanced intestinal absorption of amino acids.
[アミノ酸の腸管吸収促進確認試験]
(1)被験物質
1.トウガラシ処理物
トウガラシ処理物として、株式会社東洋新薬製の「青トウガラシ発酵エキス」を用いた。このトウガラシ処理物は以下の方法に従って調整されたものである。まず、水洗いした伏見甘長トウガラシを3mm角程度にダイスカットし、加水しながらプロセッサーで粉砕した。これにグルコースと乳酸菌を添加し、35℃にて24時間発酵させた。発酵物を60℃、200kPaにて濃縮し、デキストリンを添加した。その後、100℃にて2分間殺菌した。続けて、噴霧乾燥し、トウガラシ処理物を得た。
[Confirmation test for promotion of intestinal absorption of amino acids]
(1) Test substance 1. Processed Capsicum As the processed capsicum, “Blue Capsicum Fermented Extract” manufactured by Toyo Shinyaku Co., Ltd. was used. This processed pepper was prepared according to the following method. First, water-washed Fushimi sweet pepper was diced into pieces of about 3 mm square, and pulverized with a processor while adding water. Glucose and lactic acid bacteria were added to this and fermented at 35° C. for 24 hours. The fermentate was concentrated at 60° C. and 200 kPa and dextrin was added. Then, it was sterilized at 100°C for 2 minutes. Subsequently, it was spray-dried to obtain a chili processed product.
2.キャベツ処理物
キャベツ処理物として、株式会社東洋新薬製の「キャベツ発酵エキス」を用いた。このキャベツ処理物は下記の方法に従って調整されたものである。まず、水洗いしたキャベツを3mm角程度にダイスカットし、加水しながらプロセッサーで粉砕した。これに乳酸菌を添加し、35℃にて24時間発酵させた。発酵物を60℃、200kPaにて濃縮し、デキストリンを添加した。その後、100℃にて2分間殺菌した。続けて、噴霧乾燥し、キャベツ処理物を得た。
2. Processed Cabbage As a processed cabbage, "fermented cabbage extract" manufactured by Toyo Shinyaku Co., Ltd. was used. This processed cabbage product was prepared according to the following method. First, the cabbage washed with water was diced into pieces of about 3 mm square, and pulverized with a processor while adding water. Lactic acid bacteria were added to this and fermented at 35° C. for 24 hours. The fermentate was concentrated at 60° C. and 200 kPa and dextrin was added. Then, it was sterilized at 100°C for 2 minutes. Subsequently, it was spray-dried to obtain a processed cabbage product.
3.パパイン
パパインとして、未成熟パパイヤの種子から抽出した市販のパパイヤ抽出物粉末(タンパク質分解力価:90,000単位/g)を用いた。
3. Papain As papain, commercially available papaya extract powder (proteolytic titer: 90,000 units/g) extracted from immature papaya seeds was used.
4.ホエイタンパク(ホエイ)
ホエイタンパクとして、牛乳中の乳清タンパク質を限外ろ過処理して製造された市販の乳タンパク(タンパク質含量:80%以上)を用いた。
4. whey protein (whey)
As the whey protein, commercially available milk protein (protein content: 80% or more) produced by ultrafiltrating whey protein in cow's milk was used.
(2)被験物質の調製
・HBSS(+)Buffer(以下Bufferとする)
10×HBSS(-)100ml、NaHCO3350mg、CaCl2140mg、MgCl2・6H2O 100mg、MgSO・7H2O 100mgを950mlの超純水に溶解し、1MHCLでpH7.4に調製後、全量を1LにしてHBSS(+)Bufferを調製した。
・アミノ酸供給源濃度検討用のパパインとホエイとの混合溶液
パパインは10mg/mL、ホエイは5mg/mLとなるように上記Bufferに溶解し、等量ずつ混合した(ホエイ5mg/mL+パパイン2.5mg/mL)。混合した溶液を37℃、30minインキュベート後、ホエイ2.5mg/mL+パパイン1.25mg/mL、ホエイ1.25mg/mL+パパイン 0.625mg/mLとなるように希釈して混合溶液を調製した。
・パパインとホエイとの混合溶液にトウガラシ処理物およびキャベツ処理物を組み合わせた溶液
パパインは5000μg/mL、ホエイは2500μg/mLとなるようにBufferに溶解し、等量ずつ混合した(ホエイ2500μg/mL+パパイン1250μg/mL)。混合した溶液を37℃、30minインキュベート後、トウガラシ処理物およびキャベツ処理物と混合し、終濃度がトウガラシ処理物およびキャベツ処理物がそれぞれ200μg/mL、ホエイが1250μg/mL、パパインが625μg/mLとなるように調製した。
(2) Preparation of test substance HBSS (+) Buffer (hereinafter referred to as Buffer)
10×HBSS(−) 100 ml, NaHCO 350 mg,
・ Mixed solution of papain and whey for examining amino acid source concentration Papain was dissolved in the above buffer so that 10 mg / mL and whey was 5 mg / mL, and equal amounts were mixed (
・A solution obtained by combining processed pepper and processed cabbage with a mixed solution of papain and whey. Papain 1250 μg/mL). After incubating the mixed solution at 37° C. for 30 minutes, it was mixed with processed pepper and processed cabbage, and the final concentrations were 200 μg/mL for processed pepper and processed cabbage, 1250 μg/mL for whey, and 625 μg/mL for papain. was prepared to
(3)細胞培養
37℃、5%CO2インキュベーター内で、75cm2フラスコを用いて、通常培地(10%FBS、1%NEAA、1%P/S含有 DMEM)にてヒト大腸癌由来細胞(Caco-2)を培養した。トリプシン処理により浮遊させた細胞を、75cm2フラスコからインサートウェルに4.0×104cells/wellの細胞密度で播種した。37℃、5%CO2インキュベーター内で約10~12日間培養し、monolayerを作製した。培地交換は3~4日置きに実施した。Millicell ERS-2にて電気抵抗値を測定し、300Ω・cm2以上になっているものを使用した。また、被験物質ごとの電気抵抗値の平均が同一となるように群分けした。1000μLのBufferにてインサートウェルの外側を3回、内側を3回洗浄後、600μLのBufferが入った24wellプレート(基底膜側ウェル)に移し、インサートウェル内側(粘膜側ウェル)に100μLのBufferを添加した。CO2インキュベーター内で15分間順化した。
(3) cell culture 37 ° C., 5% CO 2 incubator, using a 75 cm 2 flask, normal medium (10% FBS, 1% NEAA, 1% P / S containing DMEM) human colon cancer-derived cells ( Caco-2) was cultured. Cells suspended by trypsinization were seeded from the 75 cm 2 flask into insert wells at a cell density of 4.0×10 4 cells/well. It was cultured in a 37° C., 5% CO 2 incubator for about 10-12 days to prepare a monolayer. Medium change was performed every 3-4 days. The electrical resistance value was measured with a Millicell ERS-2, and those with a value of 300Ω·cm 2 or more were used. In addition, the test substances were grouped so that the average electrical resistance value for each test substance was the same. After washing the outside of the insert well 3 times and the inside 3 times with 1000 μL of buffer, transfer to a 24-well plate (well on the basement membrane side) containing 600 μL of buffer, and add 100 μL of buffer to the inside of the insert well (well on the mucous membrane side). added. Acclimatized for 15 minutes in a CO2 incubator.
(4)アミノ酸供給源(ホエイ+パパイン)濃度の検討
上記細胞の順化後に、アミノ酸供給源として添加するホエイとパパインの濃度を決定するため、上記(2)のように調製した被験物質含有Bufferを、粘膜側ウェルに100μL添加し、CO2インキュベーター内で2時間培養した。また、コントロールには上記(2)のBufferを添加した。培養後、基底膜側ウェルのBufferを回収し、アミノ酸測定キット(L-Amino Acid Quantitation Kit 、BioVision製)を用いてアミノ酸量を測定した。回収したBufferとキット付属の反応試薬を、ブラックプレートにて等量混合し、37℃インキュベーターで30minインキュベートした。インキュベート後、マイクロプレートリーダーにて励起波長(Ex)/蛍光波長(Em)=535nm/587nmを測定した。また、ブランクとしてBufferの蛍光強度を差し引き、キット付属の試薬を用いて作成した検量線にてアミノ酸濃度を算出した。
(4) Examination of amino acid source (whey + papain) concentration After acclimating the cells, test substance-containing buffer prepared as in (2) above to determine the concentration of whey and papain to be added as amino acid sources. was added to the mucosal wells at 100 μL and incubated for 2 hours in a CO 2 incubator. In addition, the buffer of (2) above was added to the control. After culturing, the buffer in the basement membrane-side wells was recovered, and the amount of amino acid was measured using an amino acid measurement kit (L-Amino Acid Quantitation Kit, manufactured by BioVision). Equal amounts of the recovered buffer and the reaction reagent attached to the kit were mixed on a black plate and incubated in a 37° C. incubator for 30 minutes. After incubation, excitation wavelength (Ex)/fluorescence wavelength (Em) = 535 nm/587 nm was measured using a microplate reader. Further, as a blank, the fluorescence intensity of the buffer was subtracted, and the amino acid concentration was calculated using a calibration curve prepared using reagents attached to the kit.
(5)アミノ酸供給源のアミノ酸量の測定結果
測定結果を図1に示す。コントロールと比較し、ホエイとパパインの混合液を添加したサンプルではアミノ酸濃度が増加していた。したがって、ホエイとパパインの混合液をインキュベートすることによって、ホエイがアミノ酸やペプチドに分解され、Caco2のmonolayerを透過することが確認された。また、ホエイとパパインの濃度依存的に透過したアミノ酸量は増加していたが、濃度が高くなるにつれ透過量の変化が小さくなっていたことから、トウガラシ処理物およびキャベツ処理物との組み合わせに使用するホエイとパパインの濃度は、パパイン 1.25mg/mL+ホエイ 0.625mg/mLとした。
(5) Measurement result of amino acid amount of amino acid source The measurement result is shown in FIG. Compared to the control, the amino acid concentration increased in the sample to which the mixture of whey and papain was added. Therefore, it was confirmed that by incubating a mixed solution of whey and papain, whey is decomposed into amino acids and peptides and permeates through the Caco2 monolayer. In addition, although the amount of amino acids that permeated whey and papain increased depending on the concentration, the change in the amount of permeation decreased as the concentration increased. The concentrations of whey and papain used were 1.25 mg/mL papain + 0.625 mg/mL whey.
(6)アミノ酸供給源とトウガラシ処理物およびキャベツ処理物との組み合わせによるアミノ酸量の測定
ホエイ+パパインの濃度をそれぞれ1250μg/mL+625μg/mLとし、上記(2)に記載のようにキャベツ処理物、トウガラシ処理物と混合した被験物質含有Bufferを表1の濃度となるように調製した。調製後、上記(4)と同様に、粘膜側ウェルに100μL添加し、CO2インキュベーター内で2時間培養後、基底膜側ウェルのBufferを回収し、アミノ酸測定キットを用いてアミノ酸量を測定した。
(6) Measurement of the amount of amino acids by combining the amino acid source with the processed capsicum and the processed cabbage The concentration of whey + papain is set to 1250 µg/mL + 625 µg/mL, respectively, and the processed cabbage and capsicum are measured as described in (2) above. A test substance-containing buffer mixed with the treated material was prepared so as to have the concentration shown in Table 1. After preparation, 100 μL was added to the mucosal side wells in the same manner as in (4) above, and after 2 hours of incubation in a CO 2 incubator, the buffer in the basement membrane side wells was collected, and amino acid amounts were measured using an amino acid measurement kit. .
(7)アミノ酸供給源とトウガラシ処理物およびキャベツ処理物との組み合わせのアミノ酸量の測定結果
被験物質の詳細を表1に、測定結果を図2に示す。トウガラシ処理物はトウガラシとし、キャベツ処理物はキャベツとする。表1の数字の単位はμg/mLである。
(7) Measurement Results of Amino Acid Amounts in Combinations of Amino Acid Supply Sources with Processed Peppers and Processed Cabbage Table 1 shows the details of the test substances, and FIG. 2 shows the measurement results. A processed hot pepper is used as a hot pepper, and a processed cabbage is used as a cabbage. The unit of numbers in Table 1 is μg/mL.
比較例1(ホエイ+パパイン)のアミノ酸透過量と比較して、実施例1(ホエイ+パパイン+トウガラシ200μg/mL+キャベツ200μg/mL)において増加した透過量は、比較例2(ホエイ+パパイン+トウガラシ200μg/mL)と比較例3(ホエイ+パパイン+キャベツ200μg/mL)において増加した透過量を合計した量よりも多かった。つまり、トウガラシ処理物とキャベツ処理物を組み合わせた際のアミノ酸の透過増加効果は、トウガラシ処理物とキャベツ処理物それぞれの単独による透過増加効果を合わせたものよりも大きいことから、それぞれの効果が相加的ではなく、相乗的に働いたことによる効果だとわかった。これより、トウガラシ処理物とキャベツ処理物を組み合わせることによって、腸管におけるアミノ酸吸収促進効果が表れることが示唆された。 Compared with the amino acid permeation amount of Comparative Example 1 (whey + papain), the increased permeation amount in Example 1 (whey + papain + capsicum 200 µg/mL + cabbage 200 µg/mL) was higher than that of Comparative Example 2 (whey + papain + capsicum). 200 μg/mL) and Comparative Example 3 (whey+papain+cabbage 200 μg/mL). In other words, the effect of increasing the permeation of amino acids when the processed pepper and the processed cabbage are combined is greater than the combined effect of increasing the permeation of the processed pepper and the processed cabbage alone. It was found that the effect was not additive but synergistic. From this, it was suggested that the combination of the processed pepper and the processed cabbage exhibited an amino acid absorption promoting effect in the intestinal tract.
(8)MTTアッセイ
上記アミノ酸吸収試験における各被験物質の試験区について、MTTアッセイを行い、細胞毒性について確認した。MTTアッセイの試験方法は、以下のように行った。
(8) MTT assay MTT assay was performed on test groups of each test substance in the above amino acid absorption test to confirm cytotoxicity. The test method of the MTT assay was performed as follows.
MTT溶液は、MTTを無血清DMEMにて500μg/mLとなるように調製し、フィルター処理後使用した。MTT溶液を300μL添加した24wellプレートに上記試験終了後のインサートウェルを移し、ウェル内にも100μLのMTT溶液を添加した。37℃CO2インキュベーターで約30分インキュベートした。インキュベート後、300μLの2-プロパノールに色素を抽出し、96wellプレートに100μL移した後、570nmおよび650nmの吸光度を測定し、下記式によりMTTアッセイ値を算出した。また、下記式を用いてコントロールに対する生存率を算出した。
MTTアッセイ値 = (Abs 570-blank 570)-(Abs 650-blank 650)
生存率(%) = (Data sample/Data control )×100
The MTT solution was prepared with MTT at 500 μg/mL in serum-free DMEM and used after filtering. The insert wells after completion of the above test were transferred to a 24-well plate containing 300 μL of MTT solution, and 100 μL of MTT solution was also added to the wells. Incubated in a 37° C. CO 2 incubator for approximately 30 minutes. After incubation, the pigment was extracted with 300 μL of 2-propanol, 100 μL was transferred to a 96-well plate, absorbance at 570 nm and 650 nm was measured, and the MTT assay value was calculated according to the following formula. Also, the survival rate relative to the control was calculated using the following formula.
MTT assay value = (Abs 570-blank 570) - (Abs 650-blank 650)
Viability (%) = (Data sample/Data control) x 100
その結果各試験区において、いずれも高い生存率を示しており、細胞毒性は認められないことが確認された。 As a result, it was confirmed that all test plots showed a high survival rate and no cytotoxicity was observed.
(9)評価
以上の結果から、トウガラシ処理物およびキャベツ処理物を組み合わせた組成物は、優れたアミノ酸吸収促進作用を示し、特に腸管吸収促進作用を示すことから、腸管までアミノ酸が吸収されることにより、栄養状態の維持又は改善効果、筋肉量の増大又は維持効果、筋肉によるエネルギー産生促進による代謝改善効果、及び、筋力減少による基礎代謝の低下が招くエネルギー消費の低下と食欲不振を防ぐことによる低栄養状態の改善効果が期待できる。
(9) Evaluation From the above results, the composition in which the processed pepper and processed cabbage are combined shows excellent amino acid absorption promoting action, especially intestinal absorption promoting action, so that amino acids are absorbed into the intestinal tract. By preventing the effect of maintaining or improving nutritional status, the effect of increasing or maintaining muscle mass, the effect of improving metabolism by promoting energy production by muscles, and the decrease in energy consumption and anorexia caused by the decrease in basal metabolism due to muscle strength reduction. It can be expected to improve malnutrition.
以下に、本発明の具体的態様として配合例1~4を例示するが、本発明の組成物は以下の配合例1~4のみによって限定されるものではない。 Formulation Examples 1 to 4 are illustrated below as specific embodiments of the present invention, but the composition of the present invention is not limited only to the following Formulation Examples 1 to 4.
(配合例1:錠剤)
全体を100質量部として、トウガラシ処理物 10質量部、キャベツ処理物 8質量部、ビタミンB1 5質量部、結晶性セルロース 20質量部、乳糖 50質量部、ステアリン酸マグネシウム 4質量部及びコーンスターチ 残部を混合及び打錠することにより、錠剤の態様で本発明の吸収促進用組成物を調製した。この錠剤は、相乗的な吸収促進作用が得られるだけでなく、トウガラシ処理物の辛味や雑味などの呈味が改善されていた。また、トウガラシ処理物の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation example 1: tablet)
The total is 100 parts by mass, 10 parts by mass of processed pepper, 8 parts by mass of processed cabbage, 5 parts by mass of vitamin B1, 20 parts by mass of crystalline cellulose, 50 parts by mass of lactose, 4 parts by mass of magnesium stearate and the remainder of corn starch are mixed. and tableting to prepare the composition for promoting absorption of the present invention in the form of a tablet. This tablet not only provided a synergistic absorption-enhancing action, but also improved the taste such as the pungent taste and rough taste of the processed pepper. In addition, the peculiar fermented odor of the processed pepper was improved, and the aroma was high and the flavor was also favorable.
(配合例2:顆粒剤)
全体を100質量部として、トウガラシ処理物 10質量部、キャベツ処理物 15質量部、乳糖 10質量部、ステアリン酸カルシウム 1質量部及び結晶セルロース 残部を混合及び顆粒化することにより、顆粒剤の態様で本発明の吸収促進用組成物を調製した。この顆粒剤は、相乗的な吸収促進作用が得られるだけでなく、トウガラシ処理物の辛味や雑味などの呈味が改善されていた。また、トウガラシ処理物の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 2: Granules)
By mixing and granulating 10 parts by mass of processed red pepper, 15 parts by mass of processed cabbage, 10 parts by mass of lactose, 1 part by mass of calcium stearate and the remainder of crystalline cellulose, the present invention is prepared in the form of granules. An absorption enhancing composition of the invention was prepared. This granule not only provided a synergistic absorption promoting action, but also improved the taste such as the pungent taste and rough taste of the processed pepper. In addition, the peculiar fermented odor of the processed pepper was improved, and the aroma was high and the flavor was also favorable.
(配合例3:カプセル剤)
全体を100質量部として、トウガラシ処理物 10質量部、キャベツ処理物 20質量部、レシチン 8質量部及びオリーブ油 残部を混合して調製したものを内容液として、これをカプセル殻に内包することにより、カプセル剤の態様で本発明の吸収促進用組成物を調製した。このカプセル剤は、相乗的な吸収促進作用が得られるだけでなく、その内容物のトウガラシ処理物の辛味や雑味などの呈味が改善されていた。また内容物のトウガラシ処理物の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 3: Capsules)
The total amount is 100 parts by mass, and 10 parts by mass of processed pepper, 20 parts by mass of processed cabbage, 8 parts by mass of lecithin and the rest of olive oil are mixed and prepared as a content liquid. An absorption-enhancing composition of the present invention was prepared in the form of a capsule. Not only did this capsule provide a synergistic absorption-promoting action, but the taste of the processed pepper contained in the capsule, such as pungent taste and off-flavour, was improved. In addition, the peculiar fermented odor of the processed chili pepper contained in the contents was improved, and the aroma and flavor were high and preferable.
(配合例4:液剤)
全体を100質量部として、トウガラシ処理物 0.84質量部、キャベツ処理物 10質量部、果糖ブドウ糖液糖 10質量部、クエン酸 1質量部、安息香酸ナトリウム 0.02質量部、香料製剤 2質量部、スクラロース 0.05質量部、アセスルファムカリウム 0.03質量部及び精製水 残部を混合して、液剤の態様で本発明の吸収促進用組成物を調製した。この液剤は、相乗的な吸収促進作用が得られるだけでなく、トウガラシ処理物の辛味や雑味などの呈味が改善されていた。また、トウガラシ処理物の独特の発酵臭を改善し、香り高く風味も好ましいものであった。
(Formulation Example 4: Liquid)
The total is 100 parts by mass, 0.84 parts by mass of processed red pepper, 10 parts by mass of processed cabbage, 10 parts by mass of fructose glucose liquid sugar, 1 part by mass of citric acid, 0.02 parts by mass of sodium benzoate, 2 parts by mass of fragrance preparation parts, 0.05 parts by mass of sucralose, 0.03 parts by mass of acesulfame potassium and the balance of purified water were mixed to prepare the absorption promoting composition of the present invention in the form of a liquid formulation. This liquid preparation not only provided a synergistic absorption promoting action, but also improved the taste such as the hot taste and rough taste of the processed pepper product. In addition, the peculiar fermented odor of the processed pepper was improved, and the aroma was high and the flavor was also favorable.
本発明の一態様の組成物は、トウガラシ処理物およびキャベツ処理物を組み合わせることによって、アミノ酸吸収量の増大が確認されており、栄養状態が改善・維持され、吸収されたアミノ酸により筋肉量が増大又は維持され、筋肉によるエネルギー産生促進により代謝が改善し得るものであることから、高齢化社会における低栄養状態の症状に対する効果を望む者の健康維持に利用可能である。 The composition of one embodiment of the present invention has been confirmed to increase the absorption of amino acids by combining the processed pepper and the processed cabbage, improve and maintain nutritional status, and increase muscle mass due to the absorbed amino acids. Or it is maintained, and metabolism can be improved by promoting energy production by muscles, so it can be used for health maintenance of those who want an effect on symptoms of malnutrition in an aging society.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017072193A JP7129682B2 (en) | 2017-03-31 | 2017-03-31 | food composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017072193A JP7129682B2 (en) | 2017-03-31 | 2017-03-31 | food composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018171017A JP2018171017A (en) | 2018-11-08 |
| JP7129682B2 true JP7129682B2 (en) | 2022-09-02 |
Family
ID=64106450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017072193A Active JP7129682B2 (en) | 2017-03-31 | 2017-03-31 | food composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7129682B2 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003000141A (en) | 2002-08-28 | 2003-01-07 | Takayuki Enomoto | Sheet-like dried kimuchi and method for producing the same |
| JP2012012363A (en) | 2010-07-05 | 2012-01-19 | Echigo Yakuso:Kk | Mineral absorption enhancer |
| US20130302310A1 (en) | 2011-01-21 | 2013-11-14 | Jilin Zixin Pharmaceutical Research Institution LLC | Pharmaceutical Composition for Relieving Fatigue and Preparation Method Thereof |
| US20130302379A1 (en) | 2011-01-21 | 2013-11-14 | Jilin Zixin Pharmaceutical Research Institution Llc. | Method for Preparing Pharmaceutical Composition for Enhancing Immunity and Pharmaceutical Composition Prepared According to the Method |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3033245B2 (en) * | 1991-04-30 | 2000-04-17 | 不二製油株式会社 | Oligopeptide composition and oligopeptide-containing food |
| JP3108722B1 (en) * | 1999-09-06 | 2000-11-13 | 磐田化学工業株式会社 | Manufacturing method of fermented medicinal food |
| JP4163631B2 (en) * | 2003-01-28 | 2008-10-08 | 森永製菓株式会社 | Fermentation composition of spicy varieties of chili pepper and its use |
| JP2005013138A (en) * | 2003-06-27 | 2005-01-20 | Kiyomitsu Kawasaki | Method for producing spice flavor |
| JP2004321172A (en) * | 2004-01-14 | 2004-11-18 | Toyo Shinyaku:Kk | Intestinal environment improving food |
| KR20060105263A (en) * | 2005-04-04 | 2006-10-11 | 김기호 | Method for preparing red food-containing red food paste using parallel fermentation process of enzyme and lactic acid bacteria |
| CN102078486B (en) * | 2011-01-21 | 2012-06-20 | 吉林紫鑫药物研究有限公司 | Drug composition for removing chloasma and preparation method thereof |
| CN102078541B (en) * | 2011-01-21 | 2012-07-18 | 吉林紫鑫药物研究有限公司 | Drug composition for invigorating spleen and stomach and preparation method thereof |
| JP2012171901A (en) * | 2011-02-21 | 2012-09-10 | Fiburo Seiyaku Kk | Food for oral-intake for hair growth of men |
| PE20140635A1 (en) * | 2012-05-07 | 2014-06-06 | Nestec Sa | COMPOSITIONS OF PURE THAT HAVE SPECIFIC PROPORTIONS OF CARBOHYDRATE AND METHODS FOR USING THEM |
| KR20140032678A (en) * | 2012-09-07 | 2014-03-17 | (주)두루원 | Fermantion of aronia's extract |
-
2017
- 2017-03-31 JP JP2017072193A patent/JP7129682B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003000141A (en) | 2002-08-28 | 2003-01-07 | Takayuki Enomoto | Sheet-like dried kimuchi and method for producing the same |
| JP2012012363A (en) | 2010-07-05 | 2012-01-19 | Echigo Yakuso:Kk | Mineral absorption enhancer |
| US20130302310A1 (en) | 2011-01-21 | 2013-11-14 | Jilin Zixin Pharmaceutical Research Institution LLC | Pharmaceutical Composition for Relieving Fatigue and Preparation Method Thereof |
| US20130302379A1 (en) | 2011-01-21 | 2013-11-14 | Jilin Zixin Pharmaceutical Research Institution Llc. | Method for Preparing Pharmaceutical Composition for Enhancing Immunity and Pharmaceutical Composition Prepared According to the Method |
Non-Patent Citations (5)
| Title |
|---|
| Annals. Food Science and Technology,2014年,Vol. 15, No. 1,pp. 149-153 |
| Bulletin UASVM, Agriculture,2008年,Vol. 65, No. 2,pp. 206-211 |
| DHC美活植物醗酵液(びかつしょくぶつはっこうえき),INTERNET ARCHIVE Wayback Machine [online],2016年05月18日,[2021年9月3日検索], インターネット<URL: https://web.archive.org/web/20160518040833/http://www.dhc.co.jp/goods/goodsdetail.jsp?gCode=32376> |
| エイブリー酵素練り(5g×30包),Amazon [online],2017年02月14日,[2021年9月3日検索], インターネット<URL: https://www.amazon.co.jp/%E9%85%B5%E7%B4%A0-%E3%82%A8%E3%82%A4%E3%83%96%E3%83%AA%E3%83%BC%E9%85%B5%E7%B4%A0%E7%B7%B4%E3%82%8A%EF%BC%885g%C3%9730%E5%8C%85%EF%BC%89/dp/B06WVCXY9N>,ACIS: B06WVCXY9N |
| 乳酸キャベツでおなかすっきり 簡単に作れる発酵食,NIKKEI STYLE [online],2016年07月19日,https://style.nikkei.com/article/DGXMZO04830350U6A710C1000000/ |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018171017A (en) | 2018-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8691220B2 (en) | Powdery malted rice extract composition | |
| JP4163631B2 (en) | Fermentation composition of spicy varieties of chili pepper and its use | |
| JP6921350B1 (en) | New lactic acid bacteria belonging to Lactobacillus plantarum isolated from Yaezakura flowers and their utilization | |
| KR101276789B1 (en) | Fermented oil and a health functional food comprising the same | |
| JP2006062998A (en) | Sleep improver | |
| KR20220011937A (en) | Lactobacillus paracasei GFC_GFV5 for removing hangover and food composition comprising the same as an effective ingredient | |
| JP2004073050A (en) | Method for producing fermented plant and lactic acid fermented product | |
| KR101794637B1 (en) | Fermentation Process of a Garlic Using New Strain of Bacillus subtilis | |
| KR101720051B1 (en) | Pharmaceutical composition comprising fermented Aralia cordata Thunb for preventing or treating arthritis | |
| JP5011543B2 (en) | Method for producing fermented material containing GABA | |
| KR20170120264A (en) | Fermented chestnut puree of probiotic lactic acid bacteria and foods composition, medicinal composition including the same | |
| KR101473421B1 (en) | Composition for improving irritable bowel syndrome | |
| JP2014187949A (en) | Fermented fig product and beverage blended therewith | |
| KR20220101271A (en) | Lactobacillus gasseri GFC_1220(GFC_EJR_JOY) for alcohol metabolism enzyme activity and food composition comprising the same as an effective ingredient | |
| JP4647933B2 (en) | Composition having intestinal regulating action | |
| JP7129682B2 (en) | food composition | |
| JP2009240308A (en) | METHOD FOR PRODUCING MATERIAL CONTAINING Gamma-AMINOBUTYRIC ACID IN HIGH CONTENT | |
| JP2004267026A (en) | Health food containing papaya as main ingredient, and method for producing the same | |
| JP4803971B2 (en) | Lipid metabolism improving composition | |
| JP3366910B1 (en) | Method for increasing vitamin U content in plants | |
| KR101961903B1 (en) | Beverage composition for anti-oxidation comprising chrysanthemum flower extract short-term fermented by lactic acid bacteria and the method of preparation thereof | |
| JP7444368B1 (en) | New lactic acid bacteria belonging to Lactiplantibacillus plantarum isolated from tulip flowers and their use | |
| JP2004321172A (en) | Intestinal environment improving food | |
| JP2010252726A (en) | Antioxidant activity enhancement method for salmon and health food material | |
| JP2006265142A (en) | Body fat accumulation inhibitor or reducer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200316 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210108 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210224 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210422 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210914 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210929 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220222 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220328 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220726 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220816 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7129682 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |